Vivos Therapeutics, Inc.

NasdaqCM:VVOS Stock Report

Market Cap: US$19.9m

Vivos Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of VVOS?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders73,1411.51%
Hedge Funds250,2775.18%
Private Companies252,4985.22%
Institutions479,7649.92%
General Public3,779,62078.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 303.9%.

Top Shareholders

Top 25 shareholders own 21.83% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.18%
Armistice Capital LLC
250,277US$1.0m-58%0.02%
4.73%
Intracoastal Capital LLC
228,610US$941.9k0%7.47%
3.51%
SP Manager LLC
169,498US$698.3k0%no data
2.07%
Strategic Wealth Investment Group, LLC
100,000US$412.0k0%0.05%
1.72%
Ionic Ventures, LLC
83,000US$342.0k0%no data
1.51%
R. Huntsman
73,061US$301.0k0%no data
0.6%
Geode Capital Management, LLC
28,802US$118.7k39.2%no data
0.52%
OMERS Administration Corporation
25,000US$103.0k0%no data
0.43%
Commonwealth Equity Services, LLC
21,000US$86.5k31.3%no data
0.42%
Sabby Management, LLC
20,502US$84.5k0%0.71%
0.42%
Two Sigma Investments, LP
20,482US$84.4k0%no data
0.25%
Millennium Management LLC
12,001US$49.4k0%no data
0.22%
The Vanguard Group, Inc.
10,579US$43.6k0%no data
0.13%
Dimensional Fund Advisors LP
6,102US$25.1k0%no data
0.049%
Amundi Asset Management SAS
2,365US$9.7k0%no data
0.034%
Tower Research Capital Europe Limited
1,663US$6.9k-27.2%no data
0.016%
Osaic Wealth, Inc. , Asset Management Arm
775US$3.2k154%no data
0.012%
Advisor Group Holdings, Inc., Asset Management Arm
593US$2.4k0%no data
0.011%
SignatureFD, LLC
547US$2.3k0%no data
0.0047%
Group One Trading LP, Asset Management Arm
228US$940.30%no data
0.0033%
Thrivent Trust Company, Asset Management Arm
160US$659.40%no data
0.0016%
Merrill Lynch & Co. Inc., Banking Investments
80US$328.70%no data
0.0016%
Bradford Amman
80US$328.70%no data
0.0016%
UBS Asset Management AG
78US$320.70%no data
0.0015%
Morgan Stanley, Investment Banking and Brokerage Investments
74US$304.88.82%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/29 08:33
End of Day Share Price 2025/01/29 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vivos Therapeutics, Inc. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Scott HenryAlliance Global Partners
Edward WooAscendiant Capital Markets LLC
Lucas WardAscendiant Capital Markets LLC